Andovimpamide 100 mg 30 tablets

Andovimpamide 100 mg 30 tablets

Composition (per 1 tablet): 

Lacosamide – 100 mg. Excipients: microcrystalline cellulose, lactose, povidone, croscarmellose sodium, magnesium stearate, silicon dioxide. 

Description: 

Andovimpamid is an antiepileptic medication based on lacosamide. It selectively modulates sodium channels, stabilizes neuronal electrical activity, and reduces seizure frequency. Can be used both as monotherapy and as part of combination treatment. 

Properties: 

Reduces the risk of epileptic seizures.
Stabilizes the nervous system and normalizes brain electrical activity.
Effective for partial and generalized seizures.
Can be used alone or with other antiepileptic drugs.
Suitable for long-term therapy under medical supervision. 

Indications for Use: 

Partial-onset seizures with or without secondary generalization.
Generalized tonic-clonic seizures.
Adjunctive therapy for treatment-resistant epilepsy.

Method of Application: 

Adults: initial dose — 50 mg twice daily.
After 1 week, increase to 100 mg twice daily (200 mg/day).
Maximum daily dose — 400 mg.
Take tablets orally with sufficient water, with or without food.
Dosage and treatment duration should be determined individually by a physician. 

Storage Conditions: 

Store at +5°C…+25°C, in a dry place, protected from moisture and light. 

Packaging: 

Carton box containing 30 tablets.